Song J, Jiang H, Ding K, Liu H, et al. Zanubrutinib, lenalidomide, rituximab, temozolomide +/- methotrexate as first-line treatment for primary central nervous system lymphoma: A prospective, open-label, multicentre clinical trial. Br J Haematol 2026 Jan 26. doi: 10.1111/bjh.70335.
PMID: 41582824